Eczema Cream Recall: Amazon’s Shocking Life-Threatening Contamination!

A nationwide eczema cream recall is raising fresh concerns about contaminated products sold through Amazon and grocery stores.

Quick Take

Pharmacal is recalling one lot of MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream after the product was found to contain Staphylococcus aureus [2].
The recalled six-ounce tubes were distributed nationwide through wholesale channels, retail stores, and Amazon, including H-E-B grocery stores [2].
The Food and Drug Administration said the product could cause infections ranging from localized problems to serious or life-threatening illness [2].
No adverse events have been reported so far, but consumers are being told to stop using the cream and discard it immediately [1][2].

Why the Recall Matters

The Food and Drug Administration (FDA) says Pharmacal is pulling one lot of its MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream after contamination with Staphylococcus aureus was found [2]. The lot number is 1024088, and the tubes have an expiration date of November 2026 [2]. For families already dealing with eczema, that matters because compromised skin can give bacteria an easy path into the body.

The recall is limited to six-ounce tubes marked with product code 5106 and Universal Product Code 012277051067 [2]. The FDA says the affected product went to wholesale, retail, and internet distributors, including Amazon and H-E-B grocery stores [2]. That kind of distribution is exactly why consumers have grown wary of major chains and online marketplaces that move products quickly, often before a safety problem is widely known.

Health Risks and Who Faces the Most Danger

The FDA warning does not stop at a generic contamination notice. It says use of the product could lead to infections ranging from localized illness to severe or life-threatening adverse events [2]. People with weakened immune systems or compromised skin, including those with wounds, burns, or skin disorders, are at greater risk [2]. That is a serious public-health issue, even though no injuries have been reported yet.

Fox 4 News reported that the cream was pulled after bacteria linked to staph infections was found in the product, and it confirmed that no one had reported adverse effects at the time of the announcement [1]. That distinction matters. The recall is precautionary, not evidence that consumers were already harmed. Still, the FDA is right to move fast when a topical product can reach broken skin and potentially turn into an infection vector.

What Consumers Should Do Now

Consumers who have the recalled cream should stop using it immediately and throw it away [2]. Anyone who thinks the product caused a problem should contact a physician or health care provider [2]. Pharmacal says it is notifying distributors by email and arranging for the return of recalled product [2]. The company also listed a consumer phone number and email address for questions [2].

MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream by Pharmacal: Recall – Due to Microbial Contamination https://t.co/FGulpFosCO pic.twitter.com/wkW1qA6oTv

— US FDA MedWatch (@FDAMedWatch) May 13, 2026

This recall is a reminder that common-sense product safety still matters, especially for medicines and creams people put directly on their skin. A contaminated household product is not a minor paperwork issue; it is a failure that can become a medical problem fast. For readers tired of sloppy oversight, the lesson is simple: check lot numbers, follow recall notices, and do not assume a familiar brand is automatically safe.